About Acoramidis API

Therapeutic Category TTR Stabilizer

CAS Number 1446711-23-6

API Technology Novel API Development

Dose Form Tablets / Capsules

Synergene's Development Status Under Development

Available Regulatory Filing Under Validation / Process Optimization

Mechanism of Action

Acoramidis is currently under laboratory validation and pilot process optimization for TTR Stabilizer therapy.

Under development for TTR Stabilizer indications. Scale-up batches in progress.

Inquiry & Quotation

Connect directly with our regulatory and commercial team for batch pricing, technical specifications, and DMF documentation.

Full Name *

Work Email *

Phone

+91

Country *

Company / Organization *

I'm not a robot

reCAPTCHA